To improve child survival and health by accelerating the evaluation of and
access to new, lifesaving Pneumococcal vaccines for the world's children.
PneumoADIP is a small, dedicated team based at Johns Hopkins Bloomberg School
of Public Health and is supported by a $30 million grant from the Global
Alliance for Vaccines and Immunization. PneumoADIP aims to achieve its goals
through partnerships with countries, donors, academia, international
organizations and industry. PneumoADIP coordinates its activities through a
strategic alliance with the World Health Organization
